ELI LILLY AND COMPAN

LLY
Delayed Quote. Delayed  - 08/14 04:10:00 pm
150.09USD -0.25%
Prev.150.4600
Open149.8000
High151.6900
Low149.1500
Volume2 077 861
Latest news
1d ago
08/05
08/04
08/04
Chart ELI LILLY AND COMPANY
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishBullish
Resistance160169166
Spread/Res.-5,9%-11%-9,6%
Spread/Supp.3,0%6,1%13%
Support146142132
Financials
Sales 2020 23 790 M - -
Net income 2020 6 096 M - -
Net Debt 2020 12 033 M - -
P/E ratio 2020 22,9x
Yield 2020 1,98%
Capitalization 136 B 136 B -
EV / Sales 2020 6,22x
EV / Sales 2021 5,64x
Nbr of Employees 33 625
Free-Float 99,8%
Company
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (47.6%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (17.4%);
- veterinary medicine (12.8%);
- cardiovascular...
Sector :
Pharmaceuticals - NEC
Calendar :
2020-08-13 ELI LILLY AND COMPANY : Ex-dividend day for
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 166,81 $
Last Close Price 150,09 $
Spread / Highest target 26,6%
Spread / Average Target 11,1%
Spread / Lowest Target -20,0%